United Capital Financial Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-11,262
| Closed | -$275K | – | 1192 |
|
|
2021
Q2 | $275K | Sell |
11,262
-4,350
| -28% | -$106K | ﹤0.01% | 1042 |
|
|
2021
Q1 | $403K | Sell |
15,612
-626
| -4% | -$16.2K | ﹤0.01% | 909 |
|
|
2020
Q4 | $868K | Sell |
16,238
-3,661
| -18% | -$196K | 0.01% | 708 |
|
|
2020
Q3 | $821K | Buy |
19,899
+1,051
| +6% | +$43.4K | 0.01% | 705 |
|
|
2020
Q2 | $914K | Buy |
18,848
+403
| +2% | +$19.5K | 0.01% | 684 |
|
|
2020
Q1 | $779K | Sell |
18,445
-317
| -2% | -$13.4K | 0.01% | 689 |
|
|
2019
Q4 | $803K | Hold |
18,762
| – | – | 0.01% | 843 |
|
|
2019
Q3 | $675K | Buy |
+18,762
| New | +$675K | ﹤0.01% | 852 |
|
|
2017
Q1 | – | Sell |
-6,989
| Closed | -$202K | – | 1238 |
|
|
2016
Q4 | $202K | Sell |
6,989
-5,158
| -42% | -$149K | ﹤0.01% | 1184 |
|
|
2016
Q3 | $386K | Sell |
12,147
-620
| -5% | -$19.7K | ﹤0.01% | 1018 |
|
|
2016
Q2 | $409K | Buy |
+12,767
| New | +$409K | ﹤0.01% | 963 |
|